Aptamer-iRNAs as Therapeutics for Cancer Treatment
Aptamers are single-stranded oligonucleotides (ssDNA or ssRNA) that bind and recognize their targets with high affinity and specificity due to their complex tertiary structure. Aptamers are selected by a method called SELEX (Systematic Evolution of Ligands by EXponential enrichment). This method has...
Saved in:
Main Authors: | Mario M. Soldevilla (Author), Daniel Meraviglia-Crivelli de Caso (Author), Ashwathi P. Menon (Author), Fernando Pastor (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
by: Mayte Sola, et al.
Published: (2020) -
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
by: Daniel Meraviglia-Crivelli, et al.
Published: (2022) -
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer
by: Ashwathi Puravankara Menon, et al.
Published: (2024) -
Coupling Aptamers to Short Interfering RNAs as Therapeutics
by: Vittorio de Franciscis, et al.
Published: (2011) -
iRNA-PseU: Identifying RNA pseudouridine sites
by: Wei Chen, et al.
Published: (2016)